China Journal of Oral and Maxillofacial Surgery ›› 2023, Vol. 21 ›› Issue (2): 105-111.doi: 10.19438/j.cjoms.2023.02.001
• Original Articles • Previous Articles Next Articles
GAO Jia-min, YAO Yan-li, WANG Yu-jue, ZHANG Zhi-yuan, SUN Shu-yang
Received:
2022-10-17
Revised:
2022-12-26
Online:
2023-03-20
Published:
2023-06-12
CLC Number:
GAO Jia-min, YAO Yan-li, WANG Yu-jue, ZHANG Zhi-yuan, SUN Shu-yang. Effect of docetaxel on cell pyroptosis of head and neck squamous cell carcinoma and its mechanism[J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 105-111.
Add to citation manager EndNote|Ris|BibTeX
[1] Johnson DE, Burtness B, Leemans CR, et al.Head and neck squamous cell carcinoma[J]. Nat Rev Dis Primers, 2020, 6(1): 92-140. [2] Chow LQM.Head and neck cancer[J]. N Engl J Med, 2020, 382(1): 60-72. [3] 谭晨, 王茹, 房居高. 诱导化疗在局部中晚期头颈鳞状细胞癌治疗中的应用进展[J]. 国际耳鼻咽喉头颈外科杂志, 2019, 43(3): 159-162. Tan C, Wang R, Fang JG.Progress of the therapeutical effect with induction chemotherapy on advanced head and neck squamous cell carcinoma[J]. International Journal of Otolaryngology-Head and Neck Surgery, 2019, 43(3): 159-162. [4] Posner MR, Colevas AD, Tishler RB.The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck[J]. Semin Oncol, 2000, 27(4 Suppl 8): 13-24. [5] Geoffrois L, Martin L, De Raucourt D, et al.Induction chemotherapy followed by cetuximab radiotherapy is not superior to concurrent chemoradiotherapy for head and neck carcinomas: results of the GORTEC 2007-02 phase Ⅲ randomized trial[J]. J Clin Oncol, 2018, 36(31): 3077-3083. [6] Hitt R, Grau JJ, López-pousa A, et al. A randomized phase Ⅲ trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer[J]. Ann Oncol, 2014, 25(1): 216-225. [7] Cohen EE, Karrison TG, Kocherginsky M, et al.Phase Ⅲ randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer[J]. J Clin Oncol, 2014, 32(25): 2735-2743. [8] Haddad R, O'neill A, Rabinowits G, et al. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial[J]. Lancet Oncol, 2013, 14(3): 257-264. [9] Lefebvre J L, Andry G, Chevalier D, et al.Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891[J]. Ann Oncol, 2012, 23(10): 2708-2714. [10] Posner MR, Hershock DM, Blajman CR, et al.Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer[J]. N Engl J Med, 2007, 357(17): 1705-1715. [11] Adkins D, Ley J, Neupane P, et al.Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial[J]. Lancet Oncol, 2019, 20(9): 1295-1305. [12] Posner MR, Lefebvre JL.Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck[J]. Br J Cancer, 2003, 88(1): 11-17. [13] 董娜, 邵峰. 细胞焦亡的机制和功能[J]. 中国科学(生命科学), 2019, 49(12): 1606-1634. Dong N, Shao F.Molecular mechanism and immunological function of pyroptosis[J]. Science in China: Life Sciences,2019, 49(12): 1606-1634. [14] Zhang Z, Zhang Y, Xia S, et al.Gasdermin E suppresses tumour growth by activating anti-tumour immunity[J]. Nature, 2020, 579(7799): 415-420. [15] Wang Y, Gao W, Shi X, et al.Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin[J]. Nature, 2017, 547(7661): 99-103. [16] Rogers C, Fernandes-Alnemri T, Mayes L, et al.Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death[J]. Nat Commun, 2017, 8: 14128. [17] Westbom C, Thompson JK, Leggett A, et al.Inflammasome modulation by chemotherapeutics in malignant mesothelioma[J]. PLoS One, 2015, 10(12): e0145404. [18] Hu L, Chen M, Chen X, et al.Chemotherapy-induced pyroptosis is mediated by BAK/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate[J]. Cell Death Dis, 2020, 11(4): 281-297. [19] Wang L, Li K, Lin X, et al.Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis[J]. Cancer Lett, 2019, 450: 22-31. [20] Johnson DC, Taabazuing CY, Okondo MC, et al.DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia[J]. Nat Med, 2018, 24(8): 1151-1156. [21] Cai J, Yi M, Tan Y, et al.Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-Ⅱ[J]. J Exp Clin Cancer Res, 2021, 40(1): 190-206. [22] Zhang CC, Li CG, Wang YF, et al.Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells [23] Yu P, Wang HY, Tian M, et al.Eukaryotic elongation factor-2 kinase regulates the cross-talk between autophagy and pyroptosis in doxorubicin-treated human melanoma cells [24] Jiang M, Qi L, Li L, et al.The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer[J]. Cell Death Discov, 2020, 6: 112-123. [25] 邢栋, 王焕焕, 吕勃. 细胞程序性坏死与细胞焦亡[J]. 生理科学进展, 2020, 51(2): 113-116. Xing D, Wang HH, Lyu B.Necroptosis and pyroptosis[J]. Progress in Physiological Sciences, 2020, 51(2): 113-116. [26] Kovacs SB, Miao EA.Gasdermins: effectors of pyroptosis[J]. Trends Cell Biol, 2017, 27(9): 673-684. [27] Yu J, Li S, Qi J, et al.Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells[J]. Cell Death Dis, 2019, 10(3): 193-213. [28] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. [29] Nagata S.Apoptosis and clearance of apoptotic cells[J]. Annu Rev Immunol, 2018, 36: 489-517. [30] Mizumachi T, Suzuki S, Naito A, et al.Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cells[J]. Oncogene, 2008, 27(6): 831-838. [31] Zhu X, Yu Z, Feng L, et al.Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer[J]. Carbohydr Polym, 2021, 268: 118237. [32] Shen X, Wang H, Weng C, et al.Caspase 3/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity[J]. Cell Death Dis, 2021, 12(2): 186-202. [33] Erkes DA, Cai W, Sanchez IM, et al.Mutant BRAF and MEK inhibitors regulate the tumor immune microenvironment |
[1] | HAN Lin-zi, ZHOU Jian-hua, ZHAO Qian, DONG Lei, CHEN Zheng-gang, QIU Jian-zhong, YUAN Rong-tao. The regulation and mechanism of cancer-associated fibroblasts on tumor-infiltrating immune cells in head and neck squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 119-124. |
[2] | SHEN Meng-yuan, ZHANG Xue-ying, ZHAO Shan, XU Xin-chen, LI Xiao-dong, MENG Jian. Risk factors and clinical value of neutrophil-to-lymphocyte ratio in prediction of delirium after free flap surgery for head and neck cancer [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 131-136. |
[3] | LIU Jiang-long, JIA Fang, WANG Xiao-rong, REYILAI Abudukeremu, WUERGULI Alifu, MAIMAITITUXUN Tuerdi. Diagnostic value of contrast-enhanced ultrasound in cervical lymph node metastasis from oral and maxillofacial squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 168-174. |
[4] | REZIWANGULI·Yasen, MAIREPATI·Maiming, LI Chen-xi, GONG Zhong-cheng. Research progress in the role and mechanism of Porphyromonas gingivalis in promoting oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 186-190. |
[5] | LAN Rong, RUAN Min, HAN Nan-nan, WANG Feng. Peri-implant squamous cell carcinoma appeared after implant-restoration in the left mandible: a case report [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 203-205. |
[6] | HU Yong, WANG Qiong, ZHAO Da-yong, YE Jin-hai. Adenoid cystic carcinoma with high grade transformation and sialolithiasis of the right submandibular gland: a rare case report [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 206-208. |
[7] | WANG Jian, ZHANG Ye, HOU Cheng-su. Imaging evaluation and analysis of jaw invasion in mandibular gingival carcinoma based on micro-CT [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 36-40. |
[8] | SU Zi-shang, CUI Wen-li, ZHANG Meng-yun, YAO Zhi-tao. Relationship between cervical lymph node characteristics and prognosis in oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 41-48. |
[9] | HU Ying-kai, XU Guang-zhou, MA Zhi-gui, XIE Qian-yang, ZHANG Yong-ya, YANG Chi. Efficacy of decompression for large odontogenic maxillary sinus cysts [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 49-54. |
[10] | LI Xue-er, WANG Zheng-ye, TUERDI Maimaitituxun. Identification of HPV status in head and neck squamous cell carcinoma patients based on radiomics: diagnostic meta-analysis [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 69-74. |
[11] | LIU Heng, DUAN Xiao-feng. Research progress of ferritinophagy and related genes FTH1 and NCOA4 in oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 87-91. |
[12] | CHEN Lin, CHEN Yin-yu, DING Zi-xue, MENG Jian. A case report of AL amyloidosis complicated with multiple myeloma with dysphagia as the first symptom [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 97-101. |
[13] | GUANG Meng-kai, YUAN Xu-guang, ZHAO Rui-song, ZHU Jun-fei, ZHU Wen-xuan, JIN Jie-qi, ZHANG Ye. Buccal Rosai-Dorfman disease: a case report and literature review [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 102-104. |
[14] | GONG Xia, LI Jia, XIONG Ping, DING Ang-ang. Ultrasonography diagnosis of vascular tumors of the head and neck [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(6): 521-526. |
[15] | XI Qing. Tongue base tumor, open surgery or transoral robotic surgery? [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(6): 527-533. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||